8/40
1.0 / 5 stars
All 40 Win/Lose results and 80 gray no-data contests shown below
ACHV Roast Me summary
ACHIEVE LIFE SCIENCES, INC. (ACHV). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Win; Revenue growth No data; EPS growth No data.
- 2026-Q1: Total return Lose; Revenue growth No data; EPS growth No data.
- 2025-Q4: Total return Win; Revenue growth No data; EPS growth No data.
- 2025-Q3: Total return Win; Revenue growth No data; EPS growth No data.
Trailing 1 year (4 quarters): 3 wins, 1 losses, 8 no dataLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/1 |
WinACHV / S&P 122.11% / 15.20% |
No dataACHV / S&P / 15.00% |
No dataACHV / S&P / 50.40% |
| 2026-Q10/1 |
LoseACHV / S&P -40.85% / -4.33% |
No dataACHV / S&P / 11.30% |
No dataACHV / S&P / 27.70% |
| 2025-Q41/1 |
WinACHV / S&P 57.78% / 2.65% |
No dataACHV / S&P / 9.00% |
No dataACHV / S&P / 13.40% |
| 2025-Q31/1 |
WinACHV / S&P 39.38% / 8.12% |
No dataACHV / S&P / 4.61% |
No dataACHV / S&P / 13.45% |
| 2025-Q20/1 |
LoseACHV / S&P -15.36% / 10.94% |
No dataACHV / S&P / 4.83% |
No dataACHV / S&P / 10.63% |
| 2025-Q10/1 |
LoseACHV / S&P -24.15% / -4.27% |
No dataACHV / S&P / 4.98% |
No dataACHV / S&P / 10.57% |
| 2024-Q40/1 |
LoseACHV / S&P -25.74% / 2.41% |
No dataACHV / S&P / 5.25% |
No dataACHV / S&P / 6.15% |
| 2024-Q30/1 |
LoseACHV / S&P 0.85% / 5.89% |
No dataACHV / S&P / 5.89% |
No dataACHV / S&P / 6.11% |
| 2024-Q20/1 |
LoseACHV / S&P 3.30% / 4.28% |
No dataACHV / S&P / 5.38% |
No dataACHV / S&P / 5.12% |
| 2024-Q10/1 |
LoseACHV / S&P 10.44% / 10.56% |
No dataACHV / S&P / 5.71% |
No dataACHV / S&P / 5.59% |
| 2023-Q40/1 |
LoseACHV / S&P -4.19% / 11.69% |
No dataACHV / S&P / 6.81% |
No dataACHV / S&P / 7.78% |
| 2023-Q30/1 |
LoseACHV / S&P -17.15% / -3.27% |
No dataACHV / S&P / 7.52% |
No dataACHV / S&P / -5.03% |
| 2023-Q20/1 |
LoseACHV / S&P -23.68% / 8.74% |
No dataACHV / S&P / 9.50% |
No dataACHV / S&P / -8.57% |
| 2023-Q11/1 |
WinACHV / S&P 177.55% / 7.50% |
No dataACHV / S&P / 10.77% |
No dataACHV / S&P / -15.69% |
| 2022-Q40/1 |
LoseACHV / S&P -25.76% / 7.56% |
No dataACHV / S&P / 11.88% |
No dataACHV / S&P / -17.99% |
| 2022-Q30/1 |
LoseACHV / S&P -32.38% / -4.88% |
No dataACHV / S&P / 13.47% |
No dataACHV / S&P / -1.41% |
| 2022-Q20/1 |
LoseACHV / S&P -35.54% / -16.10% |
No dataACHV / S&P / 13.71% |
No dataACHV / S&P / 11.04% |
| 2022-Q11/1 |
WinACHV / S&P -2.70% / -4.60% |
No dataACHV / S&P / 15.97% |
No dataACHV / S&P / 42.23% |
| 2021-Q40/1 |
LoseACHV / S&P -8.47% / 11.03% |
No dataACHV / S&P / 15.00% |
No dataACHV / S&P / 96.40% |
| 2021-Q30/1 |
LoseACHV / S&P -5.35% / 0.58% |
No dataACHV / S&P / 10.77% |
No dataACHV / S&P / 69.42% |
| 2021-Q20/1 |
LoseACHV / S&P -22.45% / 8.55% |
No dataACHV / S&P / 6.58% |
No dataACHV / S&P / 51.81% |
| 2021-Q11/1 |
WinACHV / S&P 42.96% / 6.17% |
No dataACHV / S&P / -1.06% |
No dataACHV / S&P / 7.39% |
| 2020-Q40/1 |
LoseACHV / S&P -3.23% / 12.15% |
No dataACHV / S&P / -3.72% |
No dataACHV / S&P / -33.42% |
| 2020-Q30/1 |
LoseACHV / S&P 4.62% / 8.93% |
No dataACHV / S&P / -2.04% |
No dataACHV / S&P / -27.10% |
| 2020-Q21/1 |
WinACHV / S&P 21.21% / 20.54% |
No dataACHV / S&P / -0.46% |
No dataACHV / S&P / -27.11% |
| 2020-Q10/1 |
LoseACHV / S&P -37.74% / -19.60% |
No dataACHV / S&P / 3.47% |
No dataACHV / S&P / -14.75% |
| 2019-Q40/1 |
LoseACHV / S&P -68.82% / 9.07% |
No dataACHV / S&P / 5.36% |
No dataACHV / S&P / 2.99% |
| 2019-Q30/1 |
LoseACHV / S&P -11.92% / 1.70% |
No dataACHV / S&P / 5.02% |
No dataACHV / S&P / 0.21% |
| 2019-Q20/1 |
LoseACHV / S&P -40.25% / 4.30% |
No dataACHV / S&P / 6.64% |
No dataACHV / S&P / 8.65% |
| 2019-Q11/1 |
WinACHV / S&P 166.94% / 13.65% |
No dataACHV / S&P / 8.12% |
No dataACHV / S&P / 14.29% |
| 2018-Q40/1 |
LoseACHV / S&P -61.59% / -13.52% |
No dataACHV / S&P / 9.05% |
No dataACHV / S&P / 18.23% |
| 2018-Q30/1 |
LoseACHV / S&P -16.67% / 7.71% |
No dataACHV / S&P / 10.21% |
No dataACHV / S&P / 19.06% |
| 2018-Q20/1 |
LoseACHV / S&P -70.24% / 3.43% |
No dataACHV / S&P / 9.03% |
No dataACHV / S&P / 14.46% |
| 2018-Q10/1 |
LoseACHV / S&P -5.22% / -0.76% |
No dataACHV / S&P / 7.68% |
No dataACHV / S&P / 12.46% |
| 2017-Q40/1 |
LoseACHV / S&P -33.99% / 6.64% |
No dataACHV / S&P / 7.03% |
No dataACHV / S&P / 13.82% |
| 2017-Q30/1 |
LoseACHV / S&P -48.74% / 4.48% |
No dataACHV / S&P / 5.68% |
No dataACHV / S&P / 17.57% |
| 2017-Q20/1 |
LoseACHV / S&P -18.18% / 3.09% |
No dataACHV / S&P / 4.83% |
No dataACHV / S&P / 17.74% |
| 2017-Q10/1 |
LoseACHV / S&P -12.00% / 6.07% |
No dataACHV / S&P / 3.67% |
No dataACHV / S&P / 13.32% |
| 2016-Q40/1 |
LoseACHV / S&P -1.96% / 3.82% |
No dataACHV / S&P / 2.09% |
No dataACHV / S&P / 7.05% |
| 2016-Q30/1 |
LoseACHV / S&P -49.00% / 3.85% |
No dataACHV / S&P / 0.20% |
No dataACHV / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | ACHV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 172.15% | 20.78% |
| Annualized return | 172.15% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | ACHV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -0.98% | 83.14% |
| Annualized return | -0.20% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | ACHV total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.33% | 319.30% |
| Annualized return | -39.38% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |